contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Analytiker

Antti Siltanen

Modulight operates in the technology industry. The company designs, markets, and produces biomedical laser products used in oncology, genetics, and ophthalmology. The customers primarily consist of hospitals and corporate customers operating in medical technology. In addition to the main business, various value-added services are also offered. Their main market is the US.

Er der sket nogen større udvikling eller noget værd at nævne i samarbejdet mellem IQM og Modulight inden for kvanteberegning, eller er det bare et grundlæggende samarbejde? Der er set nogle artikler om emnet.

God virksomhedspræsentation. Udstråler selvtillid. Huskede også talerne om kommercialisering fra 2024. Sagde nu, at der indtil videre ikke har været noget at offentliggøre.

Ny, lige under en halv time med Modu og Orsila.https://youtu.be/tk0nQENR9DU?si=9MU7U32q6KifMSdf&t=4

Min tidligere besked i tråden for 4 år siden. Modu designer lasere, hvilket potentielt er en meget lukrativ del af værdikæden, hvis de kan skille sig ud. Jeg ser dog ingen tegn på det endnu. Hvem har fundet ud af, hvad der bliver lavet på Modus fabrik? De reklamerer med at være ”vertically integrated”, men det kan umuligt passe. Det er nok samling. De kritiske instrumenter kommer vel andre steder fra. Årsrapporten er dækket af ESG-vrøvl, jeg kan simpelthen ikke få klarhed over sagen. Hvem ved? tab 2x omsætning. For mig er Modu stadig ikke et investeringsværdigt selskab.

Jeg investerede også for nylig lidt i Modulight. Jeg har også selv lagt mærke til stilheden, tydeligvis det mest stille selskab blandt mine investeringer.

Der er stille, beklageligvis stille. Omsætningen er næsten på nul. Sådan går årene, store løfter er blevet til stilhed.

Orsila har købt 21.000 stk. Et godt tegn for mig.

Modulight

Delivery of the order is scheduled for the second half of 2025 and the first half of 2026.

Translation: Original published in Finnish on 12/20/2024 at 7:22 am EET.
Modulight announced on Thursday that it has received an order worth 0.5 MEUR from a customer in the field of next-generation therapeutics. Delivery of the order is scheduled for the second half of 2025 and the first half of 2026.
This order will contribute to the strong growth we expect for Modulight in the coming years. This year, we forecast revenue to amount to 3.9 MEUR, but to increase to 7.7 MEUR (+100%) and 10.6 MEUR (+38%) in 2025-2026. In November, the company announced <a href="https://www.inderes.se/en/analyst-comments/pay-per-treatment-model-brings-modulight-order-intake">new contracts</a> with a minimum value of 1.5 MEUR for the next two years. Thus, Modulight&apos;s revenue development in the coming years has recently gained a notch more visibility with the new agreements.

	2023	24e	25e
Omsætning	4,0	3,9	7,7
vækst-%	-12,5 %	-4,1 %	99,6 %
EBIT (adj.)	-12,1	-8,1	-6,3
EBIT-% (adj.)	-301,4 %	-210,9 %	-81,7 %
EPS (adj.)	-0,28	-0,18	-0,12
Udbytte	0,00	0,00	0,00
Udbytte %
P/E (adj.)	neg.	neg.	neg.
EV/EBITDA	neg.	neg.	neg.

Modulight receives order worth 0.5 MEUR

Key Estimate Figures22.10.2024

Forumopdateringer